ロード中...
Anlotinib as a molecular targeted therapy for tumors
Angiogenesis has an essential role in tumor growth and metastasis, and blocking this pathway has been a successfully utilized strategy in the clinical treatment of cancer. Anlotinib (AL3818) is a novel oral receptor tyrosine kinase inhibitor targeting vascular endothelial growth factor receptor 2 an...
保存先:
| 出版年: | Oncol Lett |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7377159/ https://ncbi.nlm.nih.gov/pubmed/32724339 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.11685 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|